Showing results (21-30 of 157) with videos related to
Sort By:
Pageof 16
Kidney360|April 4, 2022
Multi-Target Drugs for Kidney DiseasesJohn D Imig, Daniel Merk, Eugen ProschakCurrent Topics in Medicinal Chemistry|November 13, 2014
Medicinal chemistry and pharmacological effects of Farnesoid X Receptor (FXR) antagonistsChristina Lamers, Manfred Schubert-Zsilavecz, Daniel MerkExpert Opinion on Drug Discovery|November 23, 2013
Characterizing ligands for farnesoid X receptor--available in vitro test systems for farnesoid X receptor modulator developmentDaniel Merk, Dieter Steinhilber, Manfred Schubert-ZsilaveczExpert Opinion on Therapeutic Patents|June 16, 2012
Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present)Christina Lamers, Manfred Schubert-Zsilavecz, Daniel MerkChemmedchem|June 19, 2024
Azologs of the Fatty Acid Mimetic Drug Cinalukast Enable Light-Induced PPARα ActivationMinh Sai, Niels van Herwijnen, Daniel MerkFuture Medicinal Chemistry|June 2, 2012
Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulatorsDaniel Merk, Dieter Steinhilber, Manfred Schubert-ZsilaveczJournal of Medicinal Chemistry|March 3, 2017
Opportunities and Challenges for Fatty Acid Mimetics in Drug DiscoveryEwgenij Proschak, Pascal Heitel, Lena Kalinowsky, et al.Chemmedchem|April 12, 2019
Design of Natural-Product-Inspired Multitarget Ligands by Machine LearningFrancesca Grisoni, Daniel Merk, Lukas Friedrich, et al.Chemmedchem|October 25, 2018
Selective Optimization of Pranlukast to Farnesoid X Receptor ModulatorsSimone Schierle, Jurema Schmidt, Astrid Kaiser, et al.Scientific Reports|November 9, 2018
Scaffold-Hopping from Synthetic Drugs by Holistic Molecular RepresentationFrancesca Grisoni, Daniel Merk, Ryan Byrne, et al.Pageof 16